Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
What Makes Vertex (VERX) a Strong Momentum Stock: Buy Now?
01:05pm, Tuesday, 12'th Nov 2024
Does Vertex (VERX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Vertex: Downgrading To A Hold As Upside Is Limited
06:45am, Thursday, 07'th Nov 2024
Downgrading Vertex to neutral due to limited upside at current valuation of 10x FY25 revenue, despite robust growth outlook and strong performance. 3Q24 results exceeded expectations with $170M revenu
Vertex (VERX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:35am, Wednesday, 06'th Nov 2024
The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Vertex, Inc. (VERX) Q3 2024 Earnings Call Transcript
10:12am, Wednesday, 06'th Nov 2024
Vertex, Inc. (NASDAQ:VERX ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Joe Crivelli - Vice President, Investor Relations David DeStefano - President & Chief Exec
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
09:16am, Wednesday, 06'th Nov 2024
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. VERX, AXP, RJF and ADBE are some stocks that hold promise.
Vertex (VERX) Q3 Earnings and Revenues Surpass Estimates
09:16am, Wednesday, 06'th Nov 2024
Vertex (VERX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.10 per share a year ago.
Vertex Announces Third Quarter 2024 Financial Results
07:05am, Wednesday, 06'th Nov 2024
KING OF PRUSSIA, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial
Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It
04:13pm, Tuesday, 05'th Nov 2024
Vertex reported strong Q3 results driven by the growth of the cystic fibrosis franchise and raised the full-year revenue guidance range by $100 million at the mid-point. Casgevy finally generated comm
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
04:25pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals beat third-quarter expectations on Monday. Though the company raised its sales outlook, Vertex stock was muted.
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
04:04pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.
Vertex Reports Third Quarter 2024 Financial Results
04:01pm, Monday, 04'th Nov 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year produ
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
12:20pm, Tuesday, 29'th Oct 2024
VRTX's revenues in the third quarter of 2024 are likely to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
01:00pm, Friday, 25'th Oct 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided updates on multiple kidney diseases in its pipeline including IgA nephropathy (IgAN), primary membranous neph
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
09:15am, Thursday, 24'th Oct 2024
Its latest report of clinical data suggests it has a winner on its hands.
Vertex to Announce Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
04:05pm, Monday, 21'st Oct 2024
KING OF PRUSSIA, Pa., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2
